We use cookies on this site. By continuing to browse without changing your browser settings to block or delete cookies, you agree to the UW–Madison Cookie Notice.
University of Wisconsin School of Medicine and Public Health
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to evaluate the efficacy and safety of E2609 in subjects with Early Alzheimer’s Disease
The PI of this project was:
This project was funded by: Eisai Inc.
The term of this project was: June 2017 to January 2020
The number of subjects scanned during this project was: 10